Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published May 30, 2006 | Supplemental Material
Journal Article Open

Effect of Glycosylation on the Function of a Soluble, Recombinant Form of the Transferrin Receptor

Abstract

Production of the soluble portion of the transferrin receptor (sTFR) by baby hamster kidney (BHK) cells is described, and the effect of glycosylation on the biological function of sTFR is evaluated for the first time. The sTFR (residues 121−760) has three N-linked glycosylation sites (Asn251, Asn317, and Asn727). Although fully glycosylated sTFR is secreted into the tissue culture medium (∼40 mg/L), no nonglycosylated sTFR could be produced, suggesting that carbohydrate is critical to the folding, stability, and/or secretion of the receptor. Mutants in which glycosylation at positions 251 and 727 (N251D and N727D) is eliminated are well expressed, whereas production of the N317D mutant is poor. Analysis by electrospray ionization mass spectrometry confirms dimerization of the sTFR and the absence of the carbohydrate at the single site in each mutant. The effect of glycosylation on binding to diferric human transferrin (Fe_2 hTF), an authentic monoferric hTF with iron in the C-lobe (designated Fe_C hTF), and a mutant (designated Mut-Fe_C hTF that features a 30-fold slower iron release rate) was determined by surface plasmon resonance; a small (∼20%) but consistent difference is noted for the binding of Fe_C hTF and the Mut-Fe_C hTF to the sTFR N317D mutant. The rate of iron release from Fe_C hTF and Mut-Fe_C hTF in complex with the sTFR and the sTFR mutants at pH 5.6 reveals that only the N317D mutant has a significant effect. The carbohydrate at position 317 lies close to a region of the TFR previously shown to interact with hTF.

Additional Information

© 2006 American Chemical Society. Received 12 January 2006. Published online 5 May 2006. Published in print 1 May 2006. This work was supported by USPHS Grants R01 DK21739 (A.B.M.), R01 GM061666 (I.A.K.), and R01 DK60770 (P.J.B.) and the Howard Hughes Medical Institute (to Pamela J. Bjorkman). S.L.B. was supported by a predoctoral fellowship from the NRSA Hemostasis & Thrombosis Training Grant. J.S.K. was supported by biology funds from the Lawrence Ferguson Endowment. We thank Dr. Caroline A. Enns for the full-length human TFR cDNA clone. We also thank Julia R. Larouche and Caroline George (SURE Program) for able technical assistance. We are very grateful to the College of Medicine at the University of Vermont for a grant to purchase the Applied Photophysics (AP) SX.18MV stopped-flow spectrofluorometer and to Dr. Iwona A. Buskiewicz for showing us how to use it.

Attached Files

Supplemental Material - bi0600695si20060323_103901.pdf

Files

bi0600695si20060323_103901.pdf
Files (151.7 kB)
Name Size Download all
md5:fee21634c29f88458113f8f4dc60f07c
151.7 kB Preview Download

Additional details

Created:
August 19, 2023
Modified:
October 24, 2023